PT2.12.03 Zongertinib in Patients With Previously Treated HER2-Mutant NSCLC and Brain Metastases at Baseline: Beamion LUNG-1
Back to course
Asset Subtitle
Gerrina Ruiter
Meta Tag
Speaker Gerrina Ruiter
Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy
Powered By